Cargando…

Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review

Ovarian cancer is the fifth leading cause of cancer death among women and the most lethal gynecologic malignancy. One of the leading causes of death in high-grade serous ovarian cancer (HGSOC) is chemoresistant disease, which may present as intrinsic or acquired resistance to therapies. Here we disc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cornelison, Robert, Llaneza, Danielle C., Landen, Charles N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666852/ https://www.ncbi.nlm.nih.gov/pubmed/29057791 http://dx.doi.org/10.3390/ijms18102171

Ejemplares similares

CX-5461 Treatment Leads to Cytosolic DNA-Mediated STING Activation in Ovarian Cancer
por: Cornelison, Robert, et al.
Publicado: (2021)

Long noncoding RNAs as therapeutic targets to overcome chemoresistance in ovarian cancer
por: Chen, Linjiao, et al.
Publicado: (2022)

Epigenetic Therapies as a Promising Strategy for Overcoming Chemoresistance in Epithelial Ovarian Cancer
por: Suh, Dong Hoon, et al.
Publicado: (2013)

Targeting Lysosomes in Cancer as Promising Strategy to Overcome Chemoresistance—A Mini Review
por: Geisslinger, Franz, et al.
Publicado: (2020)

Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer
por: Emmings, Edith, et al.
Publicado: (2019)

Credentialing and Pharmacologically Targeting PTP4A3 Phosphatase as a Molecular Target for Ovarian Cancer
por: Lazo, John S., et al.
Publicado: (2021)

Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
por: Elaskalani, Omar, et al.
Publicado: (2017)

CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target
por: Feng, Xiaojie, et al.
Publicado: (2019)

Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review
por: Fajardo-Orduña, Guadalupe Rosario, et al.
Publicado: (2021)

Targeting ovarian cancer and endothelium with an allosteric PTP4A3 phosphatase inhibitor
por: McQueeney, Kelley E., et al.
Publicado: (2017)

Leptin contributes to the taxol chemoresistance in epithelial ovarian cancer
por: Gu, Fei, et al.
Publicado: (2019)

4-Methylumbelliferone Inhibits Cancer Stem Cell Activation and Overcomes Chemoresistance in Ovarian Cancer
por: Lokman, Noor A., et al.
Publicado: (2019)

Cisplatin for cancer therapy and overcoming chemoresistance
por: Ranasinghe, Ranmali, et al.
Publicado: (2022)

NANOG regulates epithelial–mesenchymal transition and chemoresistance in ovarian cancer
por: Qin, Shan, et al.
Publicado: (2017)

Targeting Cancer Stem Cells to Overcome Chemoresistance
por: Nunes, Toni, et al.
Publicado: (2018)

Editorial: Strategies in overcoming the chemoresistance in colorectal cancer
por: Vodenkova, Sona, et al.
Publicado: (2023)

Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer
por: Dobbin, Zachary C., et al.
Publicado: (2014)

Discovering drugs to overcome chemoresistance in ovarian cancers based on the cancer genome atlas tumor transcriptome profile
por: Wang, Fan, et al.
Publicado: (2017)

Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells
por: Kopecka, Joanna, et al.
Publicado: (2015)

Adipocytes promote ovarian cancer chemoresistance
por: Yang, Jiang, et al.
Publicado: (2019)

MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer
por: Silasi, Dan-Arin, et al.
Publicado: (2007)

Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer
por: Horio, Maiko, et al.
Publicado: (2012)

Chemoresistance is associated with Beclin-1 and PTEN expression in epithelial ovarian cancers
por: YING, HUANCHUN, et al.
Publicado: (2015)

Overexpression of Cathepsin L is associated with chemoresistance and invasion of epithelial ovarian cancer
por: Sui, Hongying, et al.
Publicado: (2016)

The Fhit protein: an opportunity to overcome chemoresistance
por: Gaudio, Eugenio, et al.
Publicado: (2016)

Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
por: Deng, Junli, et al.
Publicado: (2016)

Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma (Review)
por: Liao, Yu-Xin, et al.
Publicado: (2019)

Mitochondria: Insights into Crucial Features to Overcome Cancer Chemoresistance
por: Genovese, Ilaria, et al.
Publicado: (2021)

Eggmanone Effectively Overcomes Prostate Cancer Cell Chemoresistance
por: Xie, Chen, et al.
Publicado: (2021)

Targeting Glioblastoma Stem Cells to Overcome Chemoresistance: An Overview of Current Therapeutic Strategies
por: Kang, Hyunkoo, et al.
Publicado: (2022)

Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
por: Zhang, P, et al.
Publicado: (2014)

Decreased ARID1A expression is correlated with chemoresistance in epithelial ovarian cancer
por: Yokoyama, Yoshihito, et al.
Publicado: (2014)

Postoperative recurrence of epithelial ovarian cancer patients and chemoresistance related protein analyses
por: Zhang, Zhengmao, et al.
Publicado: (2019)

Associations of novel serum lipid index with epithelial ovarian cancer chemoresistance and prognosis
por: Li, Yuan, et al.
Publicado: (2023)

Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer
por: Li, Longxia, et al.
Publicado: (2022)

The emerging roles of E3 ubiquitin ligases in ovarian cancer chemoresistance
por: Meng, Yang, et al.
Publicado: (2021)

Targeted multidrug delivery system to overcome chemoresistance in breast cancer
por: Tang, Yuan, et al.
Publicado: (2017)

Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models
por: Bai, Lijuan, et al.
Publicado: (2023)

The emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer
por: Li, Xiaoduan, et al.
Publicado: (2017)

Disrupting the endothelin and Wnt relationship to overcome chemoresistance
por: Rosanò, Laura, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dj1a1ofcnhu4gseuhrivngittc